Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3017% above fair value
$367.13−1.75 (-0.47%)
Close on Nov 20, 2026Market cap $29.81BP/E 30.1Yield 0.78%
Labcorp free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Labcorp's free cash flow for the twelve months ending Sep 30, 2026 was $1.29B, down 6.8% year over year. For fiscal 2025 it was $1.21B, up 10.0% from the year before. Over ten years it grew 5.2% a year on average. The highest annual figure on record is $2.69B in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | +10.0% |
| FY2024 | Dec 31, 2024 | $1.10B | +25.4% |
| FY2023 | Dec 31, 2023 | $874.10M | -42.7% |
| FY2022 | Dec 31, 2022 | $1.53B | -43.2% |
| FY2021 | Dec 31, 2021 | $2.69B | +53.3% |
| FY2020 | Dec 31, 2020 | $1.75B | +67.9% |
| FY2019 | Dec 31, 2019 | $1.04B | +12.8% |
| FY2018 | Dec 31, 2018 | $925.60M | -21.9% |
| FY2017 | Dec 31, 2017 | $1.19B | +29.1% |
| FY2016 | Dec 31, 2016 | $918.20M | +26.4% |
| FY2015 | Dec 31, 2015 | $726.60M | +35.7% |
| FY2014 | Dec 31, 2014 | $535.50M | -13.1% |
| FY2013 | Dec 31, 2013 | $616.50M | -7.7% |
| FY2012 | Dec 31, 2012 | $667.60M | -6.0% |
| FY2011 | Dec 31, 2011 | $709.90M | -6.3% |
| FY2010 | Dec 31, 2010 | $757.50M | +1.3% |
| FY2009 | Dec 31, 2009 | $747.70M | +19.8% |
| FY2008 | Dec 31, 2008 | $624.20M | +10.1% |
| FY2007 | Dec 31, 2007 | $567.10M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $412.20M | +47.0% |
| Q2 FY2026 | Jun 30, 2026 | $313.90M | -42.2% |
| Q1 FY2026 | Mar 31, 2026 | $70.50M | – |
| Q4 FY2025 | Dec 31, 2025 | $490.30M | -26.3% |
| Q3 FY2025 | Sep 30, 2025 | $280.50M | +73.7% |
| Q2 FY2025 | Jun 30, 2025 | $542.70M | +25.4% |
| Q1 FY2025 | Mar 31, 2025 | -$107.50M | – |
| Q4 FY2024 | Dec 31, 2024 | $665.10M | +61.3% |
| Q3 FY2024 | Sep 30, 2024 | $161.50M | -5.3% |
| Q2 FY2024 | Jun 30, 2024 | $432.90M | +74.5% |
| Q1 FY2024 | Mar 31, 2024 | -$163.60M | -480.5% |
| Q4 FY2023 | Dec 31, 2023 | $412.40M | -25.6% |
| Q3 FY2023 | Sep 30, 2023 | $170.60M | -41.4% |
| Q2 FY2023 | Jun 30, 2023 | $248.10M | -43.9% |
| Q1 FY2023 | Mar 31, 2023 | $43.00M | -82.0% |
| Q4 FY2022 | Dec 31, 2022 | $554.50M | -5.4% |
| Q3 FY2022 | Sep 30, 2022 | $291.00M | -55.2% |
| Q2 FY2022 | Jun 30, 2022 | $442.30M | +13.4% |
| Q1 FY2022 | Mar 31, 2022 | $238.80M | -77.5% |
| Q4 FY2021 | Dec 31, 2021 | $586.40M | -13.2% |
| Q3 FY2021 | Sep 30, 2021 | $649.50M | -8.4% |
| Q2 FY2021 | Jun 30, 2021 | $390.00M | +43.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.06B | +992.8% |
| Q4 FY2020 | Dec 31, 2020 | $675.20M | +52.9% |
| Q3 FY2020 | Sep 30, 2020 | $709.00M | +95.3% |
| Q2 FY2020 | Jun 30, 2020 | $272.20M | +61.7% |
| Q1 FY2020 | Mar 31, 2020 | $97.20M | +35.8% |
| Q4 FY2019 | Dec 31, 2019 | $441.60M | +21.3% |
| Q3 FY2019 | Sep 30, 2019 | $363.00M | +135.7% |
| Q2 FY2019 | Jun 30, 2019 | $168.30M | -43.9% |
| Q1 FY2019 | Mar 31, 2019 | $71.60M | -33.2% |
| Q4 FY2018 | Dec 31, 2018 | $364.20M | -22.3% |
| Q3 FY2018 | Sep 30, 2018 | $154.00M | -52.1% |
| Q2 FY2018 | Jun 30, 2018 | $300.20M | +24.5% |
| Q1 FY2018 | Mar 31, 2018 | $107.20M | -30.3% |
| Q4 FY2017 | Dec 31, 2017 | $468.90M | +18.5% |
| Q3 FY2017 | Sep 30, 2017 | $321.40M | – |
| Q2 FY2017 | Jun 30, 2017 | $241.20M | – |
| Q1 FY2017 | Mar 31, 2017 | $153.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $395.80M | – |
See a number that looks wrong?